Cost-utility analysis of tapering strategies of biologicals in rheumatoid arthritis patients in the Netherlands
Conclusions
Based on these analyses, the 50% tapering approach saved the highest cost per QALY lost.
Source: Annals of the Rheumatic Diseases - Category: Rheumatology Authors: van Esveld, L., Cox, J. M., Kuijper, T. M., Bosch, T. M., Weel-Koenders, A. E. Tags: ARD, Rheumatoid arthritis Source Type: research